Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Immune Activating Properties of Host Defense® MyCommunity® Mushroom Blend Confirmed by New, Peer-Reviewed Research

Industry leader Host Defense® Mushrooms™ publishes new peer-reviewed study in the Journal of Inflammation Research that confirms immune activating properties of the 17-species beneficial mushroom blend, MyCommunity®

For centuries, mushrooms have been trusted functional foods for supporting health. Host Defense preserves this wisdom of nature and expands its impact through cutting-edge modern research. To support your healthy lifestyle, trust Host Defense to bring only the best…From the Forest, to Our Farm, to You!™ (PRNewsfoto/Fungi Perfecti, LLC)

News provided by

Fungi Perfecti

Mar 13, 2020, 10:00 ET

Share this article

Share toX

Share this article

Share toX

OLYMPIA, Wash., March 13, 2020 /PRNewswire/ -- Fungi Perfecti, LLC (makers of Host Defense® Mushrooms™) partnered with the third-party experts at Natural Immune Systems, Inc to publish a new, peer-reviewed manuscript in the highly respected international, open-access Journal of Inflammation Research. This study sought to determine the efficacy of the 17-species, proprietary beneficial mushroom blend, MyCommunity®. The results were conclusive. Host Defense® MyCommunity® was shown to be highly effective at inducing immunomodulatory events, and also assisted in a post-response return to immune system homeostasis.

Continue Reading
Host Defense MyCommunity Capsules 60 ct
Host Defense MyCommunity Capsules 60 ct

Read the new manuscript in the Journal of Inflammation Research linked here – just type "Stamets" in the search bar.

Results of the Research:
In keeping with their commitment to product efficacy and quality, and just mere months after publishing the groundbreaking research about beneficial mushroom mycelium and the fermented substrate on which it's grown, Host Defense® just released new research that demonstrates, yet again, the immune-supporting benefits of mushroom mycelium-based supplements. 

Evidence from the new, peer-reviewed study suggests that this multi-species mushroom blend, MyCommunity®, may provide complementary effects on the host immune response by:

  1. Robust up-regulation of immune cell signaling molecules that strongly engaged the immune response*
  2. Assisting in a post-response return to homeostasis within the immune system*
  3. Releasing a set of growth factors that regenerates and repairs cellular tissue in the immune system*

The results of the research on the 17-species blend, Host Defense® MyCommunity®, indicated that immune cell signaling molecules were strongly engaged.  It was also shown to not only engage responses that support immune-activation but, importantly, to also assist in a post-response return to a balanced state of homeostasis.  Furthermore, the multi-species formula of mushroom mycelium triggered the release of a set of growth factors that helps support regeneration of cellular tissue in the body. 

Data from this study also documented unique and complementary effects elicited by employing a multi-species blend of mushroom mycelium.  The various compounds provided by each different species were shown to work cooperatively and concurrently to engage a wider range of immune cells.  The numerous compounds found in the product appear to create a complementary immune response, working together to elicit a stronger and broader response than one set of compounds alone. 

Host Defense® has dedicated significant resources to testing the activity and efficacy of their products and research will continue to verify immunological and other health-supporting benefits of mushroom mycelium-based products. 

Renee Davis, R&D Director at Fungi Perfecti® commented on the significance of the research:

This study is significant as it characterizes the distinctive immune profiles of the different fractions (or chemical 'layers') of the MyCommunity® formula. We see not only immune activation, but also a modulation effect in immune cells.  We look forward to further research to elucidate the mechanisms of immunological activity, and that replicates these effects in in vivo and clinical settings.

The full article can be viewed in the Journal of Inflammation Research – just type "Stamets" in the search bar.

About Host Defense® Mushrooms™
Since its inception, Fungi Perfecti, LLC – maker of Host Defense® Mushrooms™ – has long been a favorite among consumers of natural products.  Always at the cutting edge of mycological research, the company continuously strives to find new and effective ways to support human health with the highest quality mushroom supplements.  A strong commitment to research and education is among the fundamental building blocks of the Host Defense® brand and is what continues to set them apart in the industry.  This is demonstrated by the rigorous research initiatives undertaken by the Host Defense® team.  Just last December, partnering with an independent research lab, they published yet another groundbreaking study in the journal BMC Complementary and Alternative Medicine about the immune benefits of mushroom mycelium and the fermented substrate on which it's grown.

Their ongoing dedication to science and furthering the field of mycology is evident not only in their remarkable research initiatives, but also in the fact that their staff includes 3 PhDs and 3 other full-time research scientists.  These mycologists, immunologists, and researchers are all committed not only to the testing of efficacy of Host Defense® products, but to looking for new and innovative ways to utilize the immune-supporting benefits of mushrooms and mushroom mycelium.

Fungi Perfecti launched its Host Defense® Mushrooms™ brand more than 10 years ago, providing products directly to stores and consumers. But long before that, Paul Stamets and Fungi Perfecti, LLC were well-known for their ground-breaking research in the field of mushrooms and mycological solutions to help people and planet. +  Host Defense® products are produced under the direct supervision of Paul Stamets.

Paul Stamets & Fungi Perfecti, LLC
Founder and Chief Science Officer of Fungi Perfecti, Paul Stamets has been recognized for decades as a leading innovator in the field of mycology.  Stamets has focused on revealing the health-supporting properties of the mushroom organism, with emphasis on understanding the unique benefits and capabilities of mushroom mycelium.  As a renowned researcher and author of six books and numerous peer-reviewed scientific papers, Stamets' Host Defense® mushroom formulations have long been the most sought-after and highly valued within the dietary supplement industry.

* These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure, or prevent any disease.

+ Your purchase of Host Defense® Mushrooms™ products helps support their mission to reduce carbon emissions, and also supports research to protect bees from colony collapse and conservation of rare mushrooms species in old growth forests.

SOURCE Fungi Perfecti

Related Links

http://www.fungi.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.